Teva Pharmaceutical Industries Ltd. @ 2024-01-22

Related News Article Title:
Israel’s Netanyahu rejects any Palestinian sovereignty in post-war Gaza, rebuffing Biden
Description: Netanyahu’s statement goes agaisnt President Joe Biden who said that “there are a number of types of two-state solutions.
News Sentiment: 0.0 (Neutral)

Teva Pharmaceutical Industries Limited

Sector: Healthcare

Industry: Drug Manufacturers – Specialty & Generic

Full Time Employees: 34004


Long Business Summary:

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company’s products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington’s disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration with MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia, as well as a collaboration with Sanofi to co-develop and co-commercialize TEV-48574 asset, a novel anti-TL1A therapy for the treatment of ulcerative colitis and Crohn’s disease. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Basic Chart

Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Technical Chart

Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Suggested Currency Pair: USD/ILS

Leave a Comment